Lupin gets USFDA nod for generic chronic constipation treatment drug

Lupin Limited has received the United States Food and Drug Administration approval for its generic version of Prucalopride tablets. These tablets are used for treating chronic idiopathic constipation. The approved strengths are 1 mg and 2 mg. This generic medicine is bioequivalent to Takeda Pharmaceuticals' Motegrity tablets. Lupin will manufacture the product at its Goa facility in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/UYvFxtq
via IFTTT